Cytokine-induced tumor immunogenicity: endogenous interleukin-1α expressed by fibrosarcoma cells confers reduced tumorigenicity
- 1 December 1993
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 39 (1) , 45-52
- https://doi.org/10.1016/0165-2478(93)90163-v
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cancer vaccinesImmunology Today, 1993
- Different regulatory levels are involved in the generation of hemopoietic cytokines (CSFs and IL-6) in fibroblasts stimulated by inflammatory productsCytokine, 1993
- Reduced tumorigenicity of fibrosarcomas which constitutively generate il‐1α either spontaneously or following il‐1α gene transferInternational Journal of Cancer, 1992
- Interleukin‐1 production by transformed fibroblasts. II. Influence on antigen presentation and T‐cell‐mediated anti‐tumor responseInternational Journal of Cancer, 1992
- Interleukin‐1 produced by tumorigenic fibroblasts influences tumor rejectionInternational Journal of Cancer, 1992
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Cytokines and cancer: experimental systemsCurrent Opinion in Immunology, 1991
- Regulation of interleukin 1 generation in immune‐activated fibroblastsEuropean Journal of Immunology, 1990
- Lymphokine gene therapy for cancerImmunology Today, 1990
- There is more than one interleukin 1Immunology Today, 1986